1-[4-[(3R)-3-[(ethenylsulfonylamino)methyl]pyrrolidin-1-yl]sulfonylphenyl]-N,N-dimethylcyclopropane-1-carboxamide
C19H27N3O5S2 — CID 146210891
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-[(3R)-3-[(ethenylsulfonylamino)methyl]pyrrolidin-1-yl]sulfonylphenyl]-N,N-dimethylcyclopropane-1-carboxamide
1-[4-[(3R)-3-[(ethenylsulfonylamino)methyl]pyrrolidin-1-yl]sulfonylphenyl]-N,N-dimethylcyclopropane-1-carboxamide (PubChem CID 146210891) has the molecular formula C19H27N3O5S2 and a molecular weight of 441.58 g/mol. Its IUPAC name is 1-[4-[(3R)-3-[(ethenylsulfonylamino)methyl]pyrrolidin-1-yl]sulfonylphenyl]-N,N-dimethylcyclopropane-1-carboxamide.
Molecular Properties
| Compound Name | 1-[4-[(3R)-3-[(ethenylsulfonylamino)methyl]pyrrolidin-1-yl]sulfonylphenyl]-N,N-dimethylcyclopropane-1-carboxamide |
|---|---|
| PubChem CID | 146210891 |
| Molecular Formula | C19H27N3O5S2 |
| Molecular Weight | 441.58 g/mol |
| Exact Mass | 441.14 |
| IUPAC Name | 1-[4-[(3R)-3-[(ethenylsulfonylamino)methyl]pyrrolidin-1-yl]sulfonylphenyl]-N,N-dimethylcyclopropane-1-carboxamide |
| SMILES | C=CS(=O)(=O)NC[C@H]1CCN(S(=O)(=O)c2ccc(C3(C(=O)N(C)C)CC3)cc2)C1 |
| InChI | InChI=1S/C19H27N3O5S2/c1-4-28(24,25)20-13-15-9-12-22(14-15)29(26,27)17-7-5-16(6-8-17)19(10-11-19)18(23)21(2)3/h4-8,15,20H,1,9-14H2,2-3H3/t15-/m1/s1 |
| InChIKey | XCCIMEIUESTIBE-OAHLLOKOSA-N |
| XLogP | 0.88 |
| TPSA | 103.86 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 441.58 |
| LogP ≤ 5 | 0.88 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146210891 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.